Appendix 2—table 41. Antidiabetic Non-user Cohort (Region=New York State) by BP Use, Patient Characteristics Pre/Post Match of BP Users/Non-users.
| Region=NY Antidiabetic Non-users by BP: Unmatched | Region=NY Antidiabetic Non-users by BP: Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-user | BP User | p-value | All | BP Non-user | BP User | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 104,691 | 100.0% | 95,416 | 91.1% | 9,275 | 8.9% | 18,288 | 100.0% | 9,144 | 50.0% | 9,144 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 455 | 0.4% | 455 | 0.5% | 0 | 0.0% | <0.001 | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 1.00 |
| 21-40 | 6,164 | 5.9% | 6,146 | 6.4% | 18 | 0.2% | 36 | 0.2% | 18 | 0.2% | 18 | 0.2% | ||
| 41-50 | 10,440 | 10.0% | 10,367 | 10.9% | 73 | 0.8% | 147 | 0.8% | 74 | 0.8% | 73 | 0.8% | ||
| 51-60 | 24,369 | 23.3% | 23,304 | 24.4% | 1,065 | 11.5% | 2,128 | 11.6% | 1,064 | 11.6% | 1,064 | 11.6% | ||
| 61-70 | 28,819 | 27.5% | 25,720 | 27.0% | 3,099 | 33.4% | 6,190 | 33.8% | 3,097 | 33.9% | 3,093 | 33.8% | ||
| 71-80 | 24,311 | 23.2% | 20,826 | 21.8% | 3,485 | 37.6% | 6,839 | 37.4% | 3,419 | 37.4% | 3,420 | 37.4% | ||
| ≥81 | 10,133 | 9.7% | 8,598 | 9.0% | 1,535 | 16.5% | 2,948 | 16.1% | 1,472 | 16.1% | 1,476 | 16.1% | ||
| Gender | ||||||||||||||
| Female | 60,467 | 57.8% | 52,194 | 54.7% | 8,273 | 89.2% | <0.001 | 16,291 | 89.1% | 8,146 | 89.1% | 8,145 | 89.1% | 0.98 |
| Male | 44,224 | 42.2% | 43,222 | 45.3% | 1,002 | 10.8% | 1,997 | 10.9% | 998 | 10.9% | 999 | 10.9% | ||
| Insurance | ||||||||||||||
| Commercial | 32,100 | 30.7% | 31,095 | 32.6% | 1,005 | 10.8% | <0.001 | 2,002 | 10.9% | 1,000 | 10.9% | 1,002 | 11.0% | 1.00 |
| Dual | 2,196 | 2.1% | 1,675 | 1.8% | 521 | 5.6% | 1,006 | 5.5% | 502 | 5.5% | 504 | 5.5% | ||
| Medicaid | 27,925 | 26.7% | 25,530 | 26.8% | 2,395 | 25.8% | 4,575 | 25.0% | 2,289 | 25.0% | 2,286 | 25.0% | ||
| Medicare | 42,470 | 40.6% | 37,116 | 38.9% | 5,354 | 57.7% | 10,705 | 58.5% | 5,353 | 58.5% | 5,352 | 58.5% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 37,106 | 35.4% | 34,553 | 36.2% | 2,553 | 27.5% | <0.001 | 5,039 | 27.6% | 2,518 | 27.5% | 2,521 | 27.6% | 0.96 |
| Yes | 67,585 | 64.6% | 60,863 | 63.8% | 6,722 | 72.5% | 13,249 | 72.4% | 6,626 | 72.5% | 6,623 | 72.4% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 1.32 | 1.79 | 1.32 | 1.79 | 1.37 | 1.81 | 0.007 | 1.37 | 1.78 | 1.36 | 1.78 | 1.37 | 1.79 | 0.92 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.